APA (7th ed.) Citation

Loibl, S., & Schneeweiss, A. (2017). Dual HER2-blockade with pertuzumab and trastuzumab in HER2-positive early breast cancer: A subanalysis of data from the randomized phase III GeparSepto trial. Annals of oncology, 28(3), . https://doi.org/10.1093/annonc/mdw610

Chicago Style (17th ed.) Citation

Loibl, Sibylle, and Andreas Schneeweiss. "Dual HER2-blockade with Pertuzumab and Trastuzumab in HER2-positive Early Breast Cancer: A Subanalysis of Data from the Randomized Phase III GeparSepto Trial." Annals of Oncology 28, no. 3 (2017). https://doi.org/10.1093/annonc/mdw610.

MLA (9th ed.) Citation

Loibl, Sibylle, and Andreas Schneeweiss. "Dual HER2-blockade with Pertuzumab and Trastuzumab in HER2-positive Early Breast Cancer: A Subanalysis of Data from the Randomized Phase III GeparSepto Trial." Annals of Oncology, vol. 28, no. 3, 2017, https://doi.org/10.1093/annonc/mdw610.